The Journal of Obstetrics and Gynaecology of India
did-you-know
Clinical Pearls of JOGI SERIES OF WEBINARS Click her to view
VOL. 72 NUMBER 5 September-October  2022

Successful Postpartum Outcome of Placenta In Situ in a Case of Placenta Percreta: A Case Study

Prateek Suren Swati Garg Vatsal Thakral Gitka Sharma Urvashi Sharma Nikhil Bansal

  • Download Article
  • Email Article
  • Print Article
  • Whatsapp Article

Placenta mboliz spectrum (PAS), refers to the range of pathologic adherence of the placenta into the myometrium  namely placenta mboliz, increta and percreta. Maternal morbidity and mortality is high because of severe and sometimes life-threatening haemorrhage. We report a case of placenta percreta, where with the help of interventional radiologist, we could save the uterus and decrease the post operative morbidity. A 38 year old female was referred  at 24 weeks of gestation for suspected case of placenta percreta. With regular antenatal follow up, she underwent a elective classical caserean section (CS), at 34 weeks of gestation, with bilateral uterine artery embolization, where placenta was left in situ. She remained in close follow up, with clinical examination, ultrasonography (USG), magnetic resonance imaging (MRI) and beta human chorionic gonadotrophin (hCG) levels. Except a few minor post operative complaints patient remained stable. She had to undergo postoperative cystoscopy and methotrexate therapy for haemturia due to invasion of bladder by placenta. She was followed for next 6 months with successful outcome by getting almost complete resorption of placenta and attaining normal menstrual function. With  multi disciplinary approach in a case of PAS, we could manage to leave the placenta in situ during CS and consequently, we could overcome the life threatening complications of placenta percreta and bladder morbidities, were able to avoid hysterectomy and a successful postpartum outcome was achieved. Keywords- placenta percreta, uterine artery mbolization, classical caesarean section, methotrexate

  • Download Aarticle
  • Email Aarticle
  • Print Article
  • Whatsapp Article